Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?
- 21 December 2019
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 22 (8) , 1295-1302
Abstract
Purpose To determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2 or 3 fractions of lower doses in patients treated previously with external beam irradiation in postoperative endometrial carcinoma. Methods/material From June 2003 to December 2016, 325 patients were treated with 3 different schedules of high-dose-rate brachytherapy after external beam irradiation for postoperative endometrial carcinoma. The patients were divided into 3 groups: Group-1: 125 patients were treated with 3 fractions of 4–6 Gy per fraction (3 fractions/week) between 2003 and 2008; Group-2: 93 patients were treated with 2 consecutive daily fractions of 5–6 Gy between 2008 and 2011; Group-3: 107 patients received a single fraction of 7 Gy between 2011 and 2016. Bladder and rectum complications were assessed using RTOG scores and with the objective scores of LENT-SOMA for the vagina. Statistics: the chi-square test. Results The mean follow-up of Groups 1, 2 and 3 was 95, 67 and 51 months, respectively. Three patients in Group-1, 2 in Group-2, 1 in Group-3 developed vaginal-cuff relapse (p = 0.68). No differences were found in late toxicity among the three groups. Conclusions One single dose of 7 Gy is safe and effective and may be the best treatment schedule with a similar incidence of vaginal-cuff relapses, complications and patient comfort with less hospital attendance.Keywords
Funding Information
- Fundación Científica Asociación Española Contra el Cáncer (PS141526ROVI)
This publication has 31 references indexed in Scilit:
- NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerCancer, 2015
- Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation TherapyAnnals of Surgical Oncology, 2014
- A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Three or Four Fractions of 4–5 Gy per Week in Postoperative High-Dose-Rate Brachytherapy for Endometrial CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialThe Lancet, 2010
- Revised FIGO staging for carcinoma of the endometriumInternational Journal of Gynecology & Obstetrics, 2009
- Stage II Adenocarcinoma of the Endometrium: Adjuvant Radiotherapy and Recurrence PatternsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: Current status of vaginal brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Lent soma scales for all anatomic sitesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995